4d pharma PLC (LSE:DDDD) - Share price - Overview

Stock Report

4d pharma PLC DDDD

Last Price
GBX118.25

Day Change
0.00|0.00%

As of 21/02/2019
15:07:45 GMT | GBX
Minimum 15 Minutes Delay.

Last Close118.25p
Day Range112.13 - 120.00
Mkt Cap77.45Mil
52-Wk Range88.00 - 250.00
Yield %-
ISINGB00BJL5BR07
Volume138
P/E-4.42
P/S-
P/CF-0.04

Share Price

Total Returns 21/02/2019

 Chg (%)  
More ...
4d pharma PLC7.50 
FTSE 100 TR GBP3.40
 
Financials
201520162017
More ...
Income Statement
Turnover---
Operating Profit-10.63-13.09-20.36
Net Profit-7.73-9.86-20.45
Reported EPS-12.62-15.21-31.41
Balance Sheet
Current Assets90.1174.9857.80
Non Current Assets7.2918.1819.94
Total Assets97.3993.1677.74
Current Liabilities4.314.944.98
Total Liabilities---
Total Equity92.7086.4869.79
Cash Flow
Operating Cash Flow-9.07-13.53-17.19
Net Change in Cash-27.0526.88-16.80
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
20/12/2018PurchaseDavid Robert Norwood103.0010,00010,300.00
18/12/2018PurchaseDavid Robert Norwood114.0020,00022,800.00
12/12/2018PurchaseDr Alexander James Stevenson115.0086,95699,999.00
12/12/2018PurchaseDavid Robert Norwood114.0050,00057,000.00

Company Profile

4d pharma PLC through its subsidiaries is involved in the business of research and development and manufacturing of live biotherapeutic products for the diseases such as cancer, asthma, autism, arthritis and multiple scelerosis.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 23/04/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-32.96
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Scientific OfficerDr Alexander James Stevenson
Non-Executive Director, ChairmanDavid Robert Norwood
Executive Director, Chief Executive OfficerDuncan Joseph Peyton
Non-Executive DirectorMr. Thomas Engelen
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.